Status:

COMPLETED

Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk

Lead Sponsor:

MedImmune LLC

Conditions:

Severe Respiratory Disease

Eligibility:

All Genders

1-24 years

Brief Summary

\- Estimate the incidence rate of hMPV infection detected by RT-PCR from frozen nasal wash aspirates in children at high risk for severe LRI disease (hospitalized at \<2 years of age).

Detailed Description

* A prospective, epdemiological study to estimate the incidence rate of hMPV infection as determined by RT-PCR from frozen nasal wash aspirates taken from children hospitalized with LRI who are at hig...

Eligibility Criteria

Inclusion

  • Be premature (less than 36 weeks gestation) and less than or equal to 12 months of age, and/or
  • Be less than or equal to 24 months of age with CHD (other than uncomplicated small atrial or ventricular septal defects or patent ductus arteriosus) that is judged to be hemodynamically significant, and/or
  • Be less than or equal to 24 months of age with CLD of prematurity (BPD) requiring medical intervention/management (i.e., supplemental oxygen, steroids, bronchodilators, or diuretics within the previous 6 months).
  • Hospital admission diagnosis referable to an acute lower respiratory tract infection or cardio/respiratory illness with a presumed respiratory infection (e.g., bronchiolitis, bronchitis, or pneumonia or cardiac decompensation associated with respiratory infection); admission must occur between October 1 and June 30 for northern hemisphere sites, and between March 1 and November 30 for southern hemisphere sites.
  • Study enrollment within 2 days after hospitalization.
  • Admission from the community to the Pediatric ward, Neonatal Intensive Care Unit, or the Intensive Care Unit.
  • Have written informed consent obtained from the parent or legal guardian prior to study entry.

Exclusion

  • Known HIV infection or a mother with known HIV infection.

Key Trial Info

Start Date :

December 1 2003

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2006

Estimated Enrollment :

1500 Patients enrolled

Trial Details

Trial ID

NCT00192439

Start Date

December 1 2003

End Date

December 1 2006

Last Update

May 7 2007

Active Locations (24)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (24 locations)

1

Miller Children's Hospital

Long Beach, California, United States, 90806

2

The Children's Hospital

Denver, Colorado, United States, 80218

3

Children's Memorial Hospital

Chicago, Illinois, United States, 60614

4

New England Medical Center

Boston, Massachusetts, United States, 02111